Kura Oncology

IPO

The promise of precision oncology brought to life for patients

Public · San Diego, United States · Founded 2014

Employees
51–200
Founded
2014
Business Model
B2B
Last Round
Private EquityDec 2021
Rounds
1
Type
Public

Indexed holds 3 funding rounds and 1 investor for this company. The full record is or through the API.

About

Kura Oncology's mission is to realize the promise of precision medicines to help patients with cancer lead better, longer lives. The company develops medicines that aim to treat cancer with precision, using a pipeline of novel precision medicines focused on expanding patient populations and leveraging smart treatment combinations to target tumors from multiple directions. Kura aims to help patients with cancer achieve long-lasting remission through targeted treatments.

Summary

Kura Oncology is a Biotech company based in San Diego, United States, founded in 2014. Its most recent funding was a Private Equity round in Dec 2021. Investors include EcoR1 Capital.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Post-IPO EquityPost-IPO EquityJan 2024
$150.0M

Sign up to see all 3 events

Funding: Private Equity. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Kura Oncology on Indexed.vc
<a href="https://indexed.vc/companies/kura-oncology"><img src="https://indexed.vc/api/badge/company/kura-oncology" alt="Kura Oncology on Indexed.vc" width="260" height="76" /></a>